http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3866690-D1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
filingDate 1988-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f585c0877c00afc14cea11294ff49b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165da2a2ce11addc01b882eb32b2987c
publicationDate 1992-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-3866690-D1
titleOfInvention ANTIPERSPIRANTS WITH ALPHA-2-ADRENERGIC AMINE ACTIVITY.
abstract Antiperspirant method comprises applying to the ailla a compsn. comprising an effectiVe amt. of an alpha adenegic amine (I) that has at least a substantial alpha2 adeergic amine activity component. (I) may be a pure alpha2 o a mixed alpha1 and alpha2 adrenergic amine. Specifically (I) is xylometazoline, oxymetazoline, naphazoline and/or pharmaceutically acceptable sat(s), e.g. hydochloide salt. Pref. (I) is present at 0.1-20, esp. 2-12% on total wt. of compsn.
priorityDate 1988-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4636

Total number of triples: 22.